Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauriane Quenee

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|October 31, 2007
Protective immunity against plagueClaire Cornelius, Lauriane Quenee, Deborah Anderson, et al.
Biomedical and Environmental Sciences : BES|June 14, 2008
Orf1/SpcS chaperones ExoS for type three secretion by Pseudomonas aeruginosaDa-Kang Shen, Lauriane Quenee, Mariette Bonnet, et al.
Critical Care Medicine|May 17, 2011
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumoniaRozenn Le Berre, Sophie Nguyen, Emmanuel Nowak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2006
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vectorOlivier Epaulard, Bertrand Toussaint, Lauriane Quenee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|October 31, 2007
Protective immunity against plagueClaire Cornelius, Lauriane Quenee, Deborah Anderson, et al.
Biomedical and Environmental Sciences : BES|June 14, 2008
Orf1/SpcS chaperones ExoS for type three secretion by Pseudomonas aeruginosaDa-Kang Shen, Lauriane Quenee, Mariette Bonnet, et al.
Critical Care Medicine|May 17, 2011
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumoniaRozenn Le Berre, Sophie Nguyen, Emmanuel Nowak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2006
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vectorOlivier Epaulard, Bertrand Toussaint, Lauriane Quenee, et al.
Pageof 1